October 2010 Archives

Stem Cells and Regenerative Medicine: The Controversy and the Science

In August, a federal court judge stunned scientists nationwide when he issued a temporary injunction against President Obama's expanded federal funding for embryonic stem cell research. The result? Widespread controversy and confusion. Researchers in labs throughout the country scrambled to interpret the decision and assess its immediate impact on their work. The prohibition was condemned by advocates who believe that more permissive federal funding will lead to major medical breakthroughs in the fight against such diseases as cancer, diabetes, Alzheimer's, and Parkinson's. At the same time, it was cheered by groups that oppose the research on moral grounds. Continuing this legal saga, just days ago an appeals court placed a temporary stay on the injunction as it considers the case.

Regardless of the outcome of this legal fight, the contentious debate over the ethical use of human embryos in biomedical research has gained new momentum. What does this recent court ruling mean? And how will it impact work being conducted at the U of M, home of the world's first interdisciplinary institute dedicated to stem cell research?

Robert Bruininks, Jonathan Cole, and Robert Berdahl - September 30, 2010 - University of Minnesota President Robert Bruininks speaks with Jonathan Cole, former provost and dean of faculties at Columbia University and Robert Berdahl, former chancellor of The University of California, Berkeley. As a special part of the celebration of Homecoming, the trio discuss the future of American higher education: what makes it great and how to sustain its global stature.


Powered by Movable Type 4.31-en

About this Archive

This page is an archive of entries from October 2010 listed from newest to oldest.

June 2010 is the previous archive.

November 2010 is the next archive.

Find recent content on the main index or look in the archives to find all content.